Cargando…
Cost-benefit analysis of calcium and vitamin D supplements
SUMMARY: If all adults with osteoporosis in the European Union (EU) and United States (US) used calcium and vitamin D supplements, it could prevent more than 500,000 fractures/year in the EU and more than 300,000/year in the US and save approximately €5.7 billion and US $3.3 billion annually. PURPOS...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491825/ https://www.ncbi.nlm.nih.gov/pubmed/31041620 http://dx.doi.org/10.1007/s11657-019-0589-y |
_version_ | 1783415024376610816 |
---|---|
author | Weaver, Connie M. Bischoff–Ferrari, Heike A. Shanahan, Christopher J. |
author_facet | Weaver, Connie M. Bischoff–Ferrari, Heike A. Shanahan, Christopher J. |
author_sort | Weaver, Connie M. |
collection | PubMed |
description | SUMMARY: If all adults with osteoporosis in the European Union (EU) and United States (US) used calcium and vitamin D supplements, it could prevent more than 500,000 fractures/year in the EU and more than 300,000/year in the US and save approximately €5.7 billion and US $3.3 billion annually. PURPOSE: Evaluate the cost-effectiveness of calcium/vitamin D supplementation for preventing osteoporotic fractures. METHODS: A cost-benefit analysis tool was used to estimate the net cost savings from reduced fracture-related hospital expenses if adults with osteoporosis in the EU and US used calcium/vitamin D supplements. A 14% relative risk reduction of fracture with calcium/vitamin D supplementation from a recent systematic review and meta-analysis of randomized, controlled trials was used as the basis for the benefit estimate. Other model inputs were informed by epidemiologic, clinical, and cost data (2016–2017) obtained via the medical literature or public databases. Analyses estimated the total number of avoided fractures and associated cost savings with supplement use. Net cost benefit was calculated by subtracting the supplements’ market costs from those savings. RESULTS: The > 30 million persons in the EU and nearly 11 million in US with osteoporosis experience about 3.9 million and 2.3 million fractures/year and have annual hospital costs exceeding €50 billion and $28 billion. If all persons with osteoporosis used calcium and vitamin D supplements, there would be an estimated 544,687 fewer fractures/year in the EU and 323,566 fewer in the US, saving over €6.9 billion and $3.9 billion; the net cost benefit would be €5,710,277,330 and $3,312,236,252, respectively. CONCLUSIONS: Calcium and vitamin D supplements are highly cost-effective, and expanded use could considerably reduce fractures and related costs. Although these analyses included individuals aged ≥ 50 years, the observed effects are likely driven by benefits observed in those aged ≥ 65 years. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11657-019-0589-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6491825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-64918252019-05-17 Cost-benefit analysis of calcium and vitamin D supplements Weaver, Connie M. Bischoff–Ferrari, Heike A. Shanahan, Christopher J. Arch Osteoporos Original Article SUMMARY: If all adults with osteoporosis in the European Union (EU) and United States (US) used calcium and vitamin D supplements, it could prevent more than 500,000 fractures/year in the EU and more than 300,000/year in the US and save approximately €5.7 billion and US $3.3 billion annually. PURPOSE: Evaluate the cost-effectiveness of calcium/vitamin D supplementation for preventing osteoporotic fractures. METHODS: A cost-benefit analysis tool was used to estimate the net cost savings from reduced fracture-related hospital expenses if adults with osteoporosis in the EU and US used calcium/vitamin D supplements. A 14% relative risk reduction of fracture with calcium/vitamin D supplementation from a recent systematic review and meta-analysis of randomized, controlled trials was used as the basis for the benefit estimate. Other model inputs were informed by epidemiologic, clinical, and cost data (2016–2017) obtained via the medical literature or public databases. Analyses estimated the total number of avoided fractures and associated cost savings with supplement use. Net cost benefit was calculated by subtracting the supplements’ market costs from those savings. RESULTS: The > 30 million persons in the EU and nearly 11 million in US with osteoporosis experience about 3.9 million and 2.3 million fractures/year and have annual hospital costs exceeding €50 billion and $28 billion. If all persons with osteoporosis used calcium and vitamin D supplements, there would be an estimated 544,687 fewer fractures/year in the EU and 323,566 fewer in the US, saving over €6.9 billion and $3.9 billion; the net cost benefit would be €5,710,277,330 and $3,312,236,252, respectively. CONCLUSIONS: Calcium and vitamin D supplements are highly cost-effective, and expanded use could considerably reduce fractures and related costs. Although these analyses included individuals aged ≥ 50 years, the observed effects are likely driven by benefits observed in those aged ≥ 65 years. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11657-019-0589-y) contains supplementary material, which is available to authorized users. Springer London 2019-04-30 2019 /pmc/articles/PMC6491825/ /pubmed/31041620 http://dx.doi.org/10.1007/s11657-019-0589-y Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Weaver, Connie M. Bischoff–Ferrari, Heike A. Shanahan, Christopher J. Cost-benefit analysis of calcium and vitamin D supplements |
title | Cost-benefit analysis of calcium and vitamin D supplements |
title_full | Cost-benefit analysis of calcium and vitamin D supplements |
title_fullStr | Cost-benefit analysis of calcium and vitamin D supplements |
title_full_unstemmed | Cost-benefit analysis of calcium and vitamin D supplements |
title_short | Cost-benefit analysis of calcium and vitamin D supplements |
title_sort | cost-benefit analysis of calcium and vitamin d supplements |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491825/ https://www.ncbi.nlm.nih.gov/pubmed/31041620 http://dx.doi.org/10.1007/s11657-019-0589-y |
work_keys_str_mv | AT weaverconniem costbenefitanalysisofcalciumandvitamindsupplements AT bischoffferrariheikea costbenefitanalysisofcalciumandvitamindsupplements AT shanahanchristopherj costbenefitanalysisofcalciumandvitamindsupplements |